146 related articles for article (PubMed ID: 19729283)
21. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
[TBL] [Abstract][Full Text] [Related]
22. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
[TBL] [Abstract][Full Text] [Related]
23. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of remission and recovery in schizophrenia in the Czech Republic.
Prikryl R; Kholova M; Kucerova HP; Ceskova E
Compr Psychiatry; 2013 Oct; 54(7):1111-6. PubMed ID: 23810077
[TBL] [Abstract][Full Text] [Related]
25. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
[TBL] [Abstract][Full Text] [Related]
26. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
[TBL] [Abstract][Full Text] [Related]
27. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.
Brissos S; Dias VV; Balanzá-Martinez V; Carita AI; Figueira ML
Schizophr Res; 2011 Jul; 129(2-3):133-6. PubMed ID: 21514793
[TBL] [Abstract][Full Text] [Related]
28. Correlates, change and 'state or trait' properties of insight in schizophrenia.
Wiffen BD; Rabinowitz J; Lex A; David AS
Schizophr Res; 2010 Sep; 122(1-3):94-103. PubMed ID: 20382507
[TBL] [Abstract][Full Text] [Related]
29. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
30. Association between symptomatic remission and functional outcome in first-episode schizophrenia.
Bodén R; Sundström J; Lindström E; Lindström L
Schizophr Res; 2009 Feb; 107(2-3):232-7. PubMed ID: 18957275
[TBL] [Abstract][Full Text] [Related]
31. Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study.
Üçok A; Ergül C
Schizophr Res; 2014 Sep; 158(1-3):241-6. PubMed ID: 25107850
[TBL] [Abstract][Full Text] [Related]
32. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
33. Cognitive functioning related to quality of life in schizophrenia.
Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
[TBL] [Abstract][Full Text] [Related]
34. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
Ho BC; Andreasen NC; Flaum M; Nopoulos P; Miller D
Am J Psychiatry; 2000 May; 157(5):808-15. PubMed ID: 10784476
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia.
González-Blanch C; Perez-Iglesias R; Pardo-García G; Rodríguez-Sánchez JM; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2010 Jun; 40(6):935-44. PubMed ID: 19751542
[TBL] [Abstract][Full Text] [Related]
36. Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.
Ventura J; Subotnik KL; Gitlin MJ; Gretchen-Doorly D; Ered A; Villa KF; Hellemann GS; Nuechterlein KH
Schizophr Res; 2015 Feb; 161(2-3):407-13. PubMed ID: 25499044
[TBL] [Abstract][Full Text] [Related]
37. [Psychopathologic and cognitive investigations in schizophrenia].
Farkas M
Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
[TBL] [Abstract][Full Text] [Related]
38. The concepts of remission and recovery in schizophrenia.
Leucht S; Lasser R
Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
[TBL] [Abstract][Full Text] [Related]
39. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
Addington J; Addington D
J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
[TBL] [Abstract][Full Text] [Related]
40. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
Harrow M; Jobe TH
J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
